Dry eye disease multifactorial aetiologies and complexity makes a single treatment not
functional enough to manage different subtypes. Instead, a tailored-managed-therapy plan …

Despite the advances in the management and treatment guidelines for dry eye proposed by
the Tear Film and Ocular Surface Society Dry Eye Workshop (TFOS DEWS II) in 2017, this …

Dry eye disease (DED) affects a substantial and increasing proportion of the global
population, with many affected individuals continuing to suffer symptoms despite access to …

Although the ultimate goal of dry eye disease (DED) management is to restore the ocular
surface and tear film homeostasis and address any accompanying symptoms, addressing …

THE COMPLEXITY OF DRY EYE and ocular surface disease can be overwhelming even to
experienced practitioners. The variability in symptoms, extensive case history …

Abstract On March 21, 2015, a meeting was held in London, United Kingdom, to address the
progress in targeting the unmet need for dry eye disease (DED) treatment. The meeting …

Purpose To examine clinical management and prescribing patterns for dry eye disease
(DED), in relation to severity and subtype, by eye care practitioners across the globe …

Purpose: To investigate approaches across the globe of the clinical management and
prescribing patterns for dry eye disease (DED), in relation to severity and subtype. Methods …

Abstract In September 2010, a Symposium in Florence, Italy, was held to address the unmet
need for global treatments for dry eye disease (DED). It was sponsored by The Tear Film & …

Dry eye disease (DED) is a multifactorial ocular surface condition that is highly prevalent
and often chronic, with significant associated burden. The 2017 report from the Tear Film & …